Épimède
Venture capitalLiège · Series A–Series B · 1 people tracked
✨ Fox Verdict
Sign up to see your fitStage
Series A–Series B
Check
$1.1M – $7.6M
HQ
Liège, BE
Instruments
Equity
Team · 1 people
from the firm's websiteMarc Foidart· Investment Manager
Frequently asked questions
- What stage does Épimède invest at?
- Épimède invests at the Series A, Series B stages.
- What is Épimède's typical check size?
- Épimède typically writes checks of $1.1M – $7.6M.
- What sectors does Épimède focus on?
- Épimède focuses on Biotech, Medical Devices, New Materials.
- Where is Épimède located?
- Épimède is headquartered in Liège, BE.
Similar investors
DCVC (Data Collective)
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDB Investments
Mohr Davidow Ventures
$200K – $4MEmpire State Development – New York Ventures
$500K – $1.5MPhoenix Venture Partners
$100K – $3MPhoenix Venture Partners invests in early to revenue-stage companies addressing major challenges in computing, electronics, transportation, energy, industrial, and life sciences sectors.
Featured in lists
Series A Investors & VC FirmsSeries B Investors & VC FirmsBiotech Investors & VC FirmsBiotech Series A Investors & VC FirmsMedical Devices Investors & VC FirmsMedical Devices Series A Investors & VC FirmsNew Materials Investors & VC FirmsNew Materials Series A Investors & VC FirmsBiotech Series B Investors & VC FirmsMedical Devices Series B Investors & VC FirmsNew Materials Series B Investors & VC FirmsInvestors & VC Firms in Belgium